Market closedNon-fractional
ClearPoint Neuro/CLPT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About ClearPoint Neuro
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
Ticker
CLPT
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Solana Beach, United States
Employees
107
Website
www.clearpointneuro.com
ClearPoint Neuro Metrics
BasicAdvanced
$149M
Market cap
-
P/E ratio
-$0.83
EPS
0.97
Beta
-
Dividend rate
Price and volume
Market cap
$149M
Beta
0.97
Financial strength
Current ratio
3.138
Quick ratio
2.538
Long term debt to equity
9.941
Total debt to equity
40.189
Management effectiveness
Return on assets (TTM)
-25.23%
Return on equity (TTM)
-61.42%
Valuation
Price to revenue (TTM)
5.162
Price to book
4.38
Price to tangible book (TTM)
4.49
Price to free cash flow (TTM)
-10.555
Growth
Revenue change (TTM)
24.86%
Earnings per share change (TTM)
12.14%
3-year revenue growth
23.93%
3-year earnings per share growth
24.08%
What the Analysts think about ClearPoint Neuro
Analyst Ratings
Majority rating from 3 analysts.
ClearPoint Neuro Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$7.6M
11.76%
Net income
-$4.1M
-10.87%
Profit margin
-53.94%
-20.25%
ClearPoint Neuro Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.29
-$0.20
-$0.19
-$0.16
-
Expected
-$0.19
-$0.25
-$0.20
-$0.19
-$0.18
Surprise
52.63%
-20.00%
-6.56%
-15.79%
-
ClearPoint Neuro News
AllArticlesVideos
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
GlobeNewsWire·2 weeks ago
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
PRNewsWire·2 weeks ago
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ClearPoint Neuro stock?
ClearPoint Neuro (CLPT) has a market cap of $149M as of July 06, 2024.
What is the P/E ratio for ClearPoint Neuro stock?
The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of July 06, 2024.
Does ClearPoint Neuro stock pay dividends?
No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next ClearPoint Neuro dividend payment date?
ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.
What is the beta indicator for ClearPoint Neuro?
ClearPoint Neuro (CLPT) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell ClearPoint Neuro stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.